Your browser doesn't support javascript.
loading
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study.
Pecci, Federica; Cantini, Luca; Cognigni, Valeria; Perrone, Fabiana; Mazzaschi, Giulia; Agostinelli, Veronica; Mentrasti, Giulia; Favari, Elda; Maffezzoli, Michele; Cortellini, Alessio; Rossi, Francesca; Chiariotti, Rebecca; Venanzi, Francesco Maria; Lo Russo, Giuseppe; Galli, Giulia; Proto, Claudia; Ganzinelli, Monica; Tronconi, Francesca; Morgese, Francesca; Campolucci, Carla; Moretti, Marco; Vignini, Arianna; Tiseo, Marcello; Minari, Roberta; Rocchi, Marco Luigi Bruno; Buti, Sebastiano; Berardi, Rossana.
Afiliação
  • Pecci F; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
  • Cantini L; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
  • Cognigni V; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
  • Perrone F; Fortrea, Inc., Durham, NC, USA.
  • Mazzaschi G; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
  • Agostinelli V; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Mentrasti G; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Favari E; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Maffezzoli M; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Cortellini A; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
  • Rossi F; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
  • Chiariotti R; Department of Food and Drug, University of Parma, Parma, Italy.
  • Venanzi FM; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Lo Russo G; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Galli G; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.
  • Proto C; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
  • Ganzinelli M; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
  • Tronconi F; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
  • Morgese F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Campolucci C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Moretti M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Vignini A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Tiseo M; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
  • Minari R; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
  • Rocchi MLB; SOD Medicina di Laboratorio, Azienda Ospedaliera Universitaria delle Marche, Ancona, Italy.
  • Buti S; SOD Medicina di Laboratorio, Azienda Ospedaliera Universitaria delle Marche, Ancona, Italy.
  • Berardi R; Department of Clinical Sciences, Università Politecnica delle Marche, Ancona, Italy.
Oncologist ; 29(3): e372-e381, 2024 Mar 04.
Article em En | MEDLINE | ID: mdl-37796838
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncologist Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncologist Ano de publicação: 2024 Tipo de documento: Article